The effect of acute versus chronic angina on the quality of life changes after angioplasty  by Ledley, Gary S. et al.
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spastic coronary segments in 31 patients undergoing sedal angiographio 
follow-up of vadant angina. Coronary angiograms and erg0novine provoca- 
tion tests were repeated at an interval of 45 months. While all 31 patients 
demonstrated a positive response to ergonovine initially, vasospastic respon- 
siveness persisted in only 16 patients at follow-up (Group 1) and resolved 
in the other 15 patients (Group 2). Mean luminal diameter of entire coronary 
AHA segments in a total of 170 normal or near normal coronary segments 
were measured, using a quantitative angiography analysis system (CAA$ 
II). In active vasospastio anginal period (initial and follow-up angiograms in 
Group 1, and initial angiogram in Group 2) basal tone was significantly higher 
at spastic segment than nonspastlc segments. In inactive period (follow-up 
angiegram In Group 2) basal tone was not different between previous pastic 
and nonspastio segments. The diagnostic sensitivity and specificity at 20% 
elevation of basal tone for the prediction of vasospasm were 77°/,, and 73%, 
respectively. 
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Coronary artery tone may change in proportion to the activity of variant 
angina over several years. Contrary to some previous studies, the estimation 
of basal coronary tone may be useful in the assessment of vasospastic 
activity in patients with variant angina. 
~ " ~  Eosinophil  Mediated Immunological Mechanism 
and inflammation In Vaeospastic Ang ina- -  Novel 
Coronary Risk Factor for Coronary Spasm 
SeiJl Umemoto, Nodko Minamlsono, Takahiro Iwami, Takahito Yonezawa, 
Akihisa FuJii, Takashi Fujii, Masunod Matsuzaki. YamagLchi Univ. Ube, 
Japan 
Vasospastic angina (VSA) is caused by corunary spasm. However, the mech- 
anism of VSA is yet unclear whether other mechanisms, such as inflammation 
or immunological mechanisms may cause vasospasm. In addition, recent 
studies suggested the mast cell-macrophage interaction and IgE-mediated 
atherosclerosis. To clarify the immunological mechanism in VSA, we com- 
pared hematologic values, blood chemical values, fibrinogen, C-reactive 
protein (CRP), and coronary risk factors such as cholesterol and HDL-C in 
VSA patients (pts) (n : 24) with those in stable effort angina pectoris pts 
(sAP, n : 17). 
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We also compared the relationships between all parameters examined 
and the severity in symptoms (mila; nitroglycerin (NTG) effective and short 
duration attack, n = 13, severe; NTG not effective, long duration attack and 
severe arrythmia, n = 11) in VSA. T':ero were no significant differences 
in coronary dsk factors, bo¢ly temperature, white blood cell court, CRP and 
llbrinegen between sAP and VSA. However there was a significant difference 
in eosinophll count between sAP and VSA. (sAP =, 108 :t: 48/ram a, VSA = 
254 -v 1141mm3; p = 0.0001). There were also significant differences both in 
fibdnogen p - 0.012) and eosioaphit (p = 0.0001) between mild (309 ± 82 
mg/dl, 178 + 69/mn~, respectively) and severe VSA (448 :t: 53 mg/dl, 344 
± 86/ram a. respectively). These results suggest that eosinophil-mediated 
immunological mechanism and inflammation may play an important role in 
the pathogenesis of VSA. In addition, eoslnophil court and fibrtnogen may be 
a detomlinant factor for the severity of VSA. 
F9-• - ]  Why is Onset of  Acute Infarction Myocardial Uncommon In Patients Wilh Vaeospastic Angina? 
Kyoichi Mizuno, Shirmlchi Ohkun!, Shinnya Yokoyama, 
Toshiyukl Kobayashi, Tedasn! Yamagishi, Hirokuni Etsuda, Kimio Satomura, 
Koh Arakawa, Toshio Shibuya. Chfl:;o Hokt,~;c,,'; Hospital Nipp¢, ~, Medica! 
School, and National Defense Medical College, Chiba and Saitama, Japan 
Vr~sospasm ay theoretically rupture plaque by compressing the atheroma- 
t;;us plaque. Nevedhe!ess, onset of myocardial infarction is uncommon in 
patients with vasospastio angina in contrast o unstable angina. Therefore, 
to clarify the differences of pathophysiology between two groups, we inves- 
tigated intralumlnal changes by coronary angioscopy. Twenty three patients 
with vasospastic angina and 24 with unstable angina were enrclled in the 
present study. Coronary angioscopy was performed at the site of coronary 
vasospasm immediately after drug induced or spontaneous coronzcy va- 
sospasm in patients with vasospastic angina and at the culpdt lesion within 
48 hours after an episode of pain at rest in those with unstable angina• Intima! 
injuries (intimal flap, ulceration, dissection, hemorrhage) were observed in 
the 8 patients with vasospastic angina and in the 14 with unstable angina 
(35% vs. 58%, n.s.). Xanthomatous plaques were observed in the 13 (54%) 
patients with unstable angina, but were not seen in any of the 23 patients with 
vasospastio angina (p < 0.001). White plaques were ,~een in all patients with 
vasospastic angina and in the 11(46%) with unstable angina (to < 0•001). In 
conclusion: 1) As lipid dch xanthomatous plaque is thrombogenic, the differ- 
ent character of plaque between two groups can account for the contrasting 
results of onset of acute myocardial infarction. 2) Although vasospasm may 
provoke intimal nJudes, less existence of thrombogenic plaque in patients 
with vasospastic angina does not induce the onset of acute myocardial in- 
farotion. 3) Angiosccpy can provide a new understanding of pathogenesis in 
coronary artery disease. 
V~'~'@ Altered and Circadian Variation of  Determinants 
Transient Myocardial  Ischemla in Unstable Angina 
and Non-Q Wave MI 
Deven J. Petal, Diana R. Holdright, David Mulcahy, Chades J. Knight, 
Dabble Clarke, Christine Wdght, Henry Purcell, Kim Fox• Royal Brompton 
Hospital, London, UK 
Thrombosis and coronary vasospasm may play a greater ote in the genesis 
of transient myocardial ischemia (TMI) in unstable angina (UA) and non- 
Q wave MI (NQ) than increased myocardial demand and may therefore 
have a different circadian variation to TMI in stable coronary disease. Using 
continuous ECG monitoring, the heart rate (HR) changes prior to and onset 
of TMI, and its circadian variation were assessed in 256 patients with UA and 
NQ whilst on stsndardised therapy. A 5 beat HR increase 10 rain. pdor to TMI 
was defined as representing increased myocardial demand. 132 episodes of 
TMI occurred in 32 (15.1%) UA LOts, and 44 episodes in 12 (27.3%) NQ pts (P 
= NS), with a mean HR at onset of 67.7 ± 12.7 and 70.5 ± 13.0 respectively 
(P = NS). HR increased pdor to TMI in 45% of episodes in UA, and 41% in 
NQ (P = NS). TMI activity was greatest between 10 pm to 8 am in UA and NQ 
(P < 0.05), and was evident for silent TMI as well ~ symptomatic episodes, 
irrespective of the preceding heart rate changes. 
30 ]_ n []  UA [ ]  Nq !, 
3 6 g 12 15 18 21 24 
t~e otct~y 
Conclusion: TMI in UA and NQ is associated with increased myocardial 
demand in less than half of the episodes and occurs most commonly at night 
when pro-coagulant activity and vasomotor tone are increased. This has 
implications on the choice and timing of any additional therapeutic agents. 
~ T h e  Effect o f  Acute Versus Chronic Angina on the 
Quality of  Life Change== After Ang iop lu ty  
Gary S. Ledlay, William Hirec.h, Antoinette Dowds, Dawn ~ n ,  Morris 
N. Kotler. At#err Einstein Medical Center, Ten3~ University School of 
Medicine, Phlladelr~.la, PA 
PTCA has been shown to be clinically ~ective in pa~Its both with acute 
and chronl¢ angina. However, the alfoct of PTCA on Quality of Lifo (QOL) 
¢ltang~ in patients with acute or ctvor~ asgina has not baser evaluate. 
Therefore, the ~ Oulcomes Study (MOS.36), a well validated, quart- 
tttalJve tool 1o measure OOL was edministered to 113 consecutive pa3ents, 
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prior to and 6 months after undergoing elective PTCA. The MOS-36 includes 
8 individual indices: physical roles (PR), bodily pain (BP), social functioning 
(SF), ,~metional roles (ER), mental health (MH), physical functioning, gen- 
eral health, and vitality. Acute angina, of less than 1 month duration, was 
noted in 42% of the total cohort (Group 1 ). Chmnio angina was noted in 48% 
(Group 2). Demographic and procedure; PTCA resalis were similar in the 2 
groups. Changes in the MOS-36 indices, at baseline and at fo!PJw.up, were 
compared, Group 1 had anly a positive trend in physical roles. However, 
Group 2 had statistically significant increases in physiceJ roles, bodily pain, 
and emotional roles; a positive trend in mental health and social functioning 
was ob:.awed. 
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In conclusion, 1) Differences exist in QOL changes after PTCA between 
patients with acute or chronic angina; 2) PTCA provides a significant positive 
effect on QOL on patients with chronic angina; 3) The quantitative valuation 
of QOL may Ix) an important outcome measurement for the cNaioation of 
therapeutic strategies for patients with chronic angina. 
Early Chronotropic Incompetence Predicts the 
Need for  Atropine During Oobutsmme ba'ess 
Echocerdlography 
Anne M. Hepner, David S. Bach, William F. Armstrong. University of 
Michigan Hospitals, Ann Arbor, MI 
Atropine (AT) has been used at peak dobutamine (OB) infusion dudng dobu- 
tamine stwss echocardiography (DSE) to increase sensitivity in palients (pts) 
with an inadequate heart rate (HR) response to DB. Earlier administration of 
AT may provide a more balance', ~inotropic and chronotropio response and 
petantiS~iy shorten study time. The puq0ose of this stlxly was to determine 
whofher HR at 20 mcg/kg/mio (HR 20) was predi~ive of the need for AT at 
peak DB infusion. HR response dudng DSE (10, 20, 30, 40 mcg/kg/min) was 
retrospectively evaluated at each stage in 132 pts. AT was added at peak 
infusion if the HR was < 100. Pts were divided into two groups based upon 
the need fur AT to achieve a HR > 100. 
Base HR HR 20 HR Peak HR post AT 
AT, n - 66 6~ (40.-g6) 65(48-97) 72(53-86) 102(76-144) 
No AT, n - 64 74 (55-100) 95 (70-126) 120 (100-141)) - 
Pts requiring AT were mere likely to be taking beta blockers (78°/,, versus 
17% (p < 0,001). The groups were otherwise similar in terms of age and 
use of calcium blockers. HR 20 was assessed at different threshold levels in 
terms of appropriate (APPR) or inappropriate (INAPPR) identification (ID) of 
the need fur AT. 
HR20 <05 <70 <75 
APPR ID 40/66 (61%) 47/68 (71%} 57/66(86%) 
INAPPR EO ~/~4 (2%) 2/S4 (3%) S/S4 (8%) 
HR 20 is prsdtctlve of the need for AT in the majority of Pta. Early ad" 
mintslnltion of AT may provide a mere balanced inobopin and chrono~ 
~-~,pOnes in pts who requtro it 8nd shorte~ study time potentially reducing 
adverse side-effecta. In this study If all pta wifh a HR 20 < 70 received eadY 
AT at 20 mcg/19g/mln DB, this would represent 71% of all pta who w.,~:.'d 
mquke AT at pesk. The remaining 20% of AT nKlutdng Pta could v-,:~.~ve it at 
pea~ prespac~5 stodm m requlred to ~he~ evak~ ~ advant~e of 
this tachnlque. 
[ " ~  B .e~-Blocldng Antlanginal Agent Does Not Change 
Pain i nreshold end Bets-Endorphin Level in 
Patients With Silent Myocardial Ischemla 
Bonpei Takase, Akira Kurita, Hiroyuki Hikita, Akimi Ueh~ta, Tomoo Nagai, 
Kimio Safomura, Kazusige isojlma, Hamo Nakamura. N3tional L)efense 
Medical College, S~tarna, Japan 
Pain threshold (PT} and plasma level of p endorphin (END) are involved 
in the pathogenesis of silent myocardial ischemia (SMI), Since p blocking 
agents improve SMI episodes, these agents might influence PT or END 
through reducing myocardial ischemic stimuli. To investigate the effect of p 
blocking agents on PT and END, we measured PT and plasma level of END 
at rest and peak exercise (Ex) of Irsadmill testing (TT) in 32 patients (pts, 
61 • 8 years) with angiographio documented coronary artery disease before 
and after medication. All pts had SMI _> 1 (1 > ram, 1 > min, J 60 me) in 
24 h aml0ulafory ECG monitoring (AECG) and positive TT. Blood samples 
obtained from the antecubitel vein and END (pg/ml) was assayed using 
RIA. PT (mA) was determined by electrical skin stimulation to the forearm. 
CartaQiol (CTL, 15 mg),/~ 1 selective and iSA (+), and niprediiol (NIP, 6 mg), 
non-selective and ISA (-), were given with a single blind, 2-wesk placebo- 
controlled esign and pts were randomly allocated to CTL or NIP treatment 
arm. Results were shown below. 
PT END PT END 
Placebo 1.9/2.4" 10.0114,0" Plac~se 1.7/2.2" 8.3/14.1" 
CTL 1.7/2.1" 9.8/12.8" NiP 1.8/2.3" 7.5/18.4" 
Rest/Ex; figures In table, mean; *p < 0.05 ~ Rest. 
PT and END signir.=antly increased by exercise in exeroise-inducad silent 
myocardial ischemia, and both CTL and NIP i rn~ TT results and SMI 
episodes in AECG. However. either CTL or NIP did not signircantly influence 
PT and END. Cenotus/ons; The measurement of PT and END in pts on 
b.lucking an~dangfna] med'¢a~n still provides useful information to elucidate 
the mechanisms of silent myocardial ischemia. 
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~"6"~ Open I'lea."t Without A Surgery TranMuMon: 
Multimodality Strategy in Over Forty Consecutive 
Jehovah's Witness Patients 
Todd K. Rasengert, Bob Helm, Feminand Velesco, William DeBois, 
S~muel I.P_J~, J6ffmy P. Gold, O. Wayne Isom, Karl H. Kdeger. New York 
HospitaI-ComeU Medical Center. New York, IV. Y. 
Bleeding and blood transfusion remain substantial dsks of open heart surgery 
(OHS), despite multiple iodMdual advances in blood conservation technique. 
We consequently developed an integrated strategy, and prospectively applied 
this program for all 43 Jehovah's Wifnass patients (JW), aged 2-82 years, 
requiting OHS at our institu6on since 1992. Operations performed included 
coronary bypass (CBG) with internal n~nmmy artery (n = 30,1 mop), mitml 
valve mplacament (n = 4, 2 rasps), atrial septet defict repair (n - 4), aortic 
valve r e ~  (n = 3), and CBG/aorticJmilz~ valve replacement, chronic 
type 1 dissection repair, and (pediatric) anffio root reconstnc~n (n = 1 
each). The Intngmted program included: 1) apm1~in (full dese regimen), 2) 
high dose e~thropeiathl (800 U/kg Initial dose, 500 U/I,,o every other day), 
3) maximum volume (co~nuous circuit) InVasperetive autologn,s dar~n 
(target on-bypass hematcodt pet] 18%, mean volume w~dckawa: 1200 =~), 
4) reVognzcfo autologous pump priming, 5) on-bypass hemoconcant~on, 
and 6) smali volume byT.,z,~ circuitry. A subset analysis was performed of 
the 30 JW CBG pts vs 30 CBG pts operated on dudng tho same ti,n~ 
pedod who were evenly matched for established transfusion risk faciom, 
including age, ge,-,d~,-, red cell mass/hct, and ~.~pidn/hepadn use. There was 
no d~emnoa in mortality, stroke, ronel failure, or m ' ~  i:/farotion rata. 
No JW received any blood transfusion, compared wdh 17(57%) contxol pts 
(1.8 :b p_8 expesu~ p < 0,01 ). Chest lobe ~aJnage 24 hr pest-op was 
380 ~ 200 ml vs 1000:1:320 ml (p < 0.001), and hcts were 32:1: 6% vs 28 
:1: 4% at 24 hr (p < 0.001) and34 ±3%ve 30 ± 4% at clay 6 pest-op (p = 
0.02S) io JW and comrof pts, ~ .  The DRG-correcLad past-op ~;gth 
of Stay and ovecall coats were decroased In JW ~ control Pts. Thase msuRs 
sugOasz tlmt an thtegretad comewa~ stretagy can markadly rsduce the 
nesd fur blond Uandus~s In OHS In a safe and ,'ost-effective mannec 
